{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:37:22Z","timestamp":1791999442380,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Aggressive angiomyxoma (AA) is a rare mesenchymal neoplasm occurring almost exclusively in the vulvovaginal region and which has a wide differential diagnosis. It has previously been suggested that the nuclear transcription factor HMGA2 is a useful marker of AA, although the number of studies is limited. We investigated HMGA2 immunoreactivity in a large series (n=284) of vulvovaginal mesenchymal lesions. HMGA2 nuclear staining was classified as diffuse (\u226550%), focal (&lt;50%), or negative. Of 38 cases of AA, 26 (68%) were positive; 77% (n=20) of these exhibited diffuse staining. Of the 41 smooth muscle tumors, 18 (44%) were positive with 16 (89%) exhibiting diffuse staining. 80 fibroepithelial stromal polyps were included and 15 (19%) were positive (8 diffuse; 7 focal). Most of the fibroepithelial stromal polyps that exhibited diffuse HMGA2 immunoreactivity were large and edematous. Occasional cases of a variety of other lesions were positive, including 1 of 30 superficial myofibroblastomas and 1 of 16 angiomyofibroblastomas. Cellular angiofibromas (n=12) and superficial angiomyxomas (n=6) were always negative. Our results confirm that HMGA2 is a useful marker of AA but a significant minority of cases are negative. The marker also lacks specificity, since a high percentage of smooth muscle tumors are positive, although these typically do not bear a close morphologic resemblance to AA. A novel observation in our study is positive staining of some fibroepithelial stromal polyps, particularly when large and edematous; these are particularly likely to be confused morphologically with AA and positive staining with HMGA2 represents a significant diagnostic pitfall.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000689","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T17:00:11Z","timestamp":1599411611000},"page":"185-189","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["HMGA2 Is a Useful Marker of Vulvovaginal Aggressive Angiomyxoma But May Be Positive in Other Mesenchymal Lesions at This Site"],"prefix":"10.1097","volume":"40","author":[{"given":"Robert","family":"Harkness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1097-0142(19960701)78:1<79::AID-CNCR13>3.0.CO;2-4","article-title":"Aggressive angiomyxoma: a clinicopathologic study of 29 females","volume":"78","author":"Fetsch","year":"1996","journal-title":"Cancer"},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/ijgc-00009577-200501000-00021","article-title":"Aggressive angiomyxoma of the female genital tract: a clinicopathologic and immunohistochemcial study of 12 cases","volume":"15","author":"Amezcua","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000478-198307000-00009","article-title":"Aggressive angiomyxoma of the female pelvis and peritoneum. Report of nine cases of a distinctive type gynaecologic soft tissue neoplasm","volume":"7","author":"Steeper","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"R4-20250802","first-page":"26","article-title":"A review and update of morphologically bland vulvovaginal mesenchymal lesions","volume":"24","author":"McCluggage","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2559.2008.03098.x","article-title":"Recent developments in vulvovaginal pathology","volume":"54","author":"McCluggage","year":"2009","journal-title":"Histopathology"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/PAS.0b013e3181e32a11","article-title":"HMGA2 is a sensitive but not specific immunohistochemical marker of vulvovaginal aggressive angiomyxoma","volume":"7","author":"McCluggage","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/00000478-199211000-00004","article-title":"Aggressive angiomyxoma. A report of four cases in men","volume":"16","author":"Tsang","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00004347-199710000-00006","article-title":"Superficial angiomyxoma (cutaneous myxoma): a clinopathological study of 17 cases arising in the genital region","volume":"16","author":"Fetsch","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2559.1991.tb01479.x","article-title":"Smooth muscle tumours of the external genitalia: clinicopathological analysis of a series","volume":"18","author":"Newman","year":"1991","journal-title":"Histopathology"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2559.2005.02063.x","article-title":"Superficial myofibroblastoma of the lower female genital tract: report of a series including tumours with a vulval location","volume":"46","author":"Ganesan","year":"2005","journal-title":"Histopathology"},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/01.pas.0000138002.46650.95","article-title":"Cellular angiofibroma:clinicopathologic and immunohistochemical analysis of 51 cases","volume":"28","author":"Iwasa","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/hupa.2001.25588","article-title":"Superficial cervicovaginal myofibroblastoma: fourteen cases of a distinctive mesenchymal tumor arising from the specialized subepithelial stroma of the lower female genital tract","volume":"32","author":"Laskin","year":"2001","journal-title":"Hum Pathol"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2559.2004.01923.x","article-title":"Cellular angiofibroma and related fibromatous lesions of the vulva: report of a series of cases with a morphological spectrum wider than previously described","volume":"45","author":"McCluggage","year":"2004","journal-title":"Histopathology"},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/PGP.0b013e31816017a7","article-title":"Massive vulval edema secondary to obesity and immobilization: a potential mimic of aggressive angiomyxoma","volume":"27","author":"McCluggage","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2559.2000.00865.x","article-title":"Vulvovaginal soft tissue tumours: update and review","volume":"36","author":"Nucci","year":"2000","journal-title":"Histopathology"},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00000478-199706000-00002","article-title":"Cellular angiofibroma: a benign neoplasm distance from angiomyofibroblastoma and spindle cell lipoma","volume":"21","author":"Nucci","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/jcp.53.8.603","article-title":"Aggressive angiomyxoma of the pelvic parts exhibiting oesterogen and progesterone receptor positivity","volume":"53","author":"McCluggage","year":"2000","journal-title":"J Clin Pathol"},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/gcc.1179","article-title":"Chromosomal translocation t(8:12) induced aberrant HMGIC expression in aggressive angiomyxoma of the vulva","volume":"32","author":"Nucci","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cancergencyto.2007.11.008","article-title":"Aggressive angiomyxoma with t(12:21) and HMGA2 rearrangement: report of a case and review of the literature","volume":"181","author":"Rawlinson","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-4608(96)85316-7","article-title":"Cytogenetic findings in a case of angiomyxoma of the vaginal wall","volume":"84","author":"Betz","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0165-4608(91)90436-X","article-title":"Aggressive angiomyxoma of the pelvis: cytogenetic findings in a single case","volume":"56","author":"Horman","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/gcc.20483","article-title":"Frequency and characterization of HMGA2 and HMGA1 rearrangements in mesenchymal tumors of the lower female genital tract","volume":"46","author":"Medeiros","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00428-006-0186-5","article-title":"Deregulation of HMGA2 in an aggressive angiomyxoma with t(11;12) (q23;q15)","volume":"448","author":"Micci","year":"2006","journal-title":"Virchows Arch"},{"key":"R24-20250802","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.pgp.0000209572.54457.7b","article-title":"HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma","volume":"25","author":"Rabban","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"R25-20250802","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/modpathol.2010.174","article-title":"Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases","volume":"23","author":"Dreux","year":"2010","journal-title":"Mod Pathol"},{"key":"R26-20250802","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/labinvest.3780040","article-title":"HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes","volume":"80","author":"Tallini","year":"2000","journal-title":"Lab Invest"},{"key":"R27-20250802","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/gcc.10159","article-title":"Intravenous leiomyomatosis is characterized by a der(14)t(12;14)(q15;q24)","volume":"36","author":"Dal Cin","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"R28-20250802","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/PGP.0000000000000096","article-title":"Uterine fibroids: do we deal with more than one disease?","volume":"33","author":"Markowski","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R29-20250802","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/gcc.22643","article-title":"Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations","volume":"57","author":"Xie","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"R30-20250802","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00000478-200002000-00009","article-title":"Cellular pseudosarcomatous fibroepithelial stromal polyps of the lower female genital tract: an underrecognized lesion often misdiagnosed as sarcoma","volume":"24","author":"Nucci","year":"2000","journal-title":"Am J Surg Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:06:38Z","timestamp":1754161598000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000689","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,4]]}}}